2016
DOI: 10.1097/mcg.0000000000000395
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective, Multicenter Study of the AIMS65 Score Compared With the Glasgow-Blatchford Score in Predicting Upper Gastrointestinal Hemorrhage Outcomes

Abstract: The AIMS65 score is superior to the GBRS for predicting in-hospital mortality and hospital length of stay for patients with UGIH. The AIMS65 score and GBRS are similar in predicting 30-day mortality, rebleeding, and a composite endpoint.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
30
1
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 54 publications
(36 citation statements)
references
References 10 publications
3
30
1
2
Order By: Relevance
“…We recommend that patients with gbs ≤1 at presentation are considered for outpatient management Level of evidence: Moderate Level of recommendation: Strong Agreement: 100% Agreement Bundle recommendation: Consider discharge if GBS 0 or 1 (100% agreement) Several comparative studies have assessed preendoscopy and postendoscopy risk scores in AUGIB. [38][39][40][41][42][43][44][45][46][47][48][49] These studies confirm GBS is the best at predicting the clinically important composite end point of need for hospital-based intervention (transfusion, endoscopic therapy, interventional radiology, surgery) or death, with high sensitivity at 98.6%. 39 The clinical utility of existing risk scores to identify patients at high risk of poor outcomes appear limited.…”
Section: Risk Stratificationmentioning
confidence: 69%
“…We recommend that patients with gbs ≤1 at presentation are considered for outpatient management Level of evidence: Moderate Level of recommendation: Strong Agreement: 100% Agreement Bundle recommendation: Consider discharge if GBS 0 or 1 (100% agreement) Several comparative studies have assessed preendoscopy and postendoscopy risk scores in AUGIB. [38][39][40][41][42][43][44][45][46][47][48][49] These studies confirm GBS is the best at predicting the clinically important composite end point of need for hospital-based intervention (transfusion, endoscopic therapy, interventional radiology, surgery) or death, with high sensitivity at 98.6%. 39 The clinical utility of existing risk scores to identify patients at high risk of poor outcomes appear limited.…”
Section: Risk Stratificationmentioning
confidence: 69%
“…Both the studies published in this issue validate the utility of UGIB scores in Indian patients, with the caution from Rout et al that they may not perform as well in the variceal UGIB cohort. There are large prospective studies similar to those of Chandnani et al and Rout et al with more or less similar published results [11][12][13]. There are several unanswered questions.…”
mentioning
confidence: 63%
“…Multiple large prospective studies have proved the utility of these scores in predicting the need for interventions, prolonged hospitalization, and mortality [11][12][13]. It was also possible to segregate a group of patients who were at low risk and did not need hospital admission.…”
mentioning
confidence: 99%
“…The possible reason may be that more patients with peptic ulcer bleeding had advanced hepatocellular carcinoma and severe multiple organ injuries. Although international guidelines recommend that risk factors should be evaluated for acute UGIB patients [17][18], no specialized scoring system for acute UGIB in liver cirrhosis patients are available right now. In our study, AIMS65, Rockall and Glasgow-Blatch-ford scores were not proved to be independent risk factors for 42-day morality.…”
Section: Discussionmentioning
confidence: 99%